Gefitinib Recruiting Phase 2 Trials for Tumors Metastatic to Brain / Non-Small Cell Lung Carcinoma (NSCLC) / EGFR Gene Mutations Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01951469Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer